Get notified when MDT files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NYSE: MDT Medtronic plc 8-K

Medtronic names Dr. Kweli Thompson to lead Neuroscience as Brett Wall departs

Filed May 18, 2026 · Period ending May 18, 2026 · ~1 min read

Key Changes

  • medium

    Dr. Kweli Thompson, currently SVP and President of Cardiac Rhythm Management, promoted to EVP and President of Neuroscience Portfolio effective June 1, 2026, replacing departing Brett Wall.

  • medium

    Brett Wall departing as EVP and President of Neuroscience Portfolio; will remain through September 1, 2026 to assist with transition and receive standard executive severance.

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (QRED 10-Q) is open in full — no account needed.

Partner

Trade MDT commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 22, 2026 12:05 AM